Danish enzymes and ingredients firms Novozymes and Chr. Hansen have announced that their post-merger name will be Novonesis. This is derived from the Latin word for ‘new’ that is already in Novozymes’ name and the Green for ‘origin’ or ‘beginning’, to acknowledge the role Ancient Greek thinkers played in the development of science.

Novozymes and Chr. Hansen have agreed to merge in what will be the largest ever such move between two Danish firms. The combined entity would have sales of €3.5 billion/year. Revenue synergies upwards of over €200 million and 6-8%/year growth to 2025 are expected.